005

Treatment of Thrombocytopenia in Patients with Chronic ITP

TREPTORA (eltrombopag) is indicated for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with chronic immune (idiopathic) thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. TREPTORA (eltrombopag) should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increase the risk for bleeding.

Treatment of Thrombocytopenia in Patients with Hepatitis C Infection

TREPTORA (eltrombopag) is indicated for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. TREPTORA (eltrombopag) should be used only in patients with chronic hepatitis C whose degree of thrombocytopenia prevents the initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy.

 

Treatment of Severe Aplastic Anemia

TREPTORA (eltrombopag) is indicated for the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.